34 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
) CannAmide™, a proprietary Palmitoylethanolamide, or PEA, formulation. PEA is an endogenous fatty acid amide that belongs to the class of nuclear factor … of nuclear factor agonists, which are molecules that regulate the expression of genes. We believe that the combination of THC and PEA may induce
6-K
EX-99.1
SPRC
SciSparc Ltd
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
and Investment Agreement, signed on March 10, 2022 (the “Agreement”).
MitoCareX Bio is a drug discovery company focusing on targeting the nuclear encoded
6-K
EX-99.2
SPRC
SciSparc Ltd
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
, and (2) CannAmide™, a proprietary PEA formulation. PEA is an endogenous fatty acid amide that belongs to the class of nuclear factor agonists, which
6-K
EX-99.2
xwptlw
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.2
vfvprkuhg7io 8lvyn
16 Aug 21
Interim Consolidated Financial Statements
12:00am
424B4
1z0it0gn5q 2ug
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
sumcp1r 6f
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
ld3rzo5 9po9m
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.2
fxhbe5mmy hsrod
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
y8oou
9 Oct 20
Registration statement (foreign) (amended)
12:00am
F-1
agzrs
8 Sep 20
Registration statement (foreign)
5:31pm
424B4
74kbto1gh2 w1b
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
qfmvjti2
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
qocwbcppcnl6rm
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
ivhserr
26 Mar 20
Registration statement (foreign) (amended)
12:00am